AGRX logo

Agile Therapeutics (AGRX) Depreciation And Amortization

Annual D&A

$386.00 K
-$1.15 M-74.84%

December 31, 2023

Summary

Performance

1-Year Change

-74.84%

3-Year Change

+39.86%

5-Year Change

+1578.26%

15-Year Change

+1578.26%

AGRX Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$2.22 M
AGRX annual depreciation & amortization is currently -82.64% below its historical high of $2.22 million

3-Year Low

$386.00 K
AGRX annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
AGRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
AGRX next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$39.48 M
AGRX annual total expenses is $39.48 million

Annual Operating Expenses

$30.50 M
AGRX annual total operating expenses is $30.50 million

Annual Cost Of Goods Sold

$8.98 M
AGRX annual cost of goods sold is $8.98 million

Annual Interest Expense

$1.42 M
AGRX annual interest expense is $1.42 million

Quarterly D&A

$102.00 K
-$1000.00-0.97%

June 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

AGRX Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$593.00 K
AGRX quarterly depreciation & amortization is currently -82.80% below its historical high of $593.00 thousand

3-Year Low

$91.00 K
AGRX quarterly depreciation & amortization is currently +12.09% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
AGRX previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

N/A
AGRX next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$8.32 M
AGRX quarterly total expenses is $8.32 million

Quarterly Operating Expenses

$6.83 M
AGRX quarterly total operating expenses is $6.83 million

Quarterly Cost Of Goods Sold

$1.50 M
AGRX quarterly cost of goods sold is $1.50 million

Quarterly Interest Expense

$0.00
AGRX quarterly interest expense is $0.00

TTM D&A

$403.00 K
+$7000.00+1.77%

June 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

AGRX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$2.31 M
AGRX TTM depreciation & amortization is currently -82.54% below its historical high of $2.31 million

3-Year Low

$377.00 K
AGRX TTM depreciation & amortization is currently +6.90% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
AGRX previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

N/A
AGRX next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$39.48 M
AGRX annual total expenses is $39.48 million

Annual Operating Expenses

$30.50 M
AGRX annual total operating expenses is $30.50 million

TTM Cost Of Goods Sold

$7.84 M
AGRX TTM cost of goods sold is $7.84 million

TTM Interest Expense

$831.00 K
AGRX TTM interest expense is $831.00 thousand

AGRX Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-74.8%0.0%0.0%
3 y3 years+39.9%0.0%0.0%
5 y5 years+1578.3%0.0%0.0%

AGRX Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-82.6%at low-82.8%-10.8%-82.5%-6.5%
5 y5-year-82.6%-57.8%-82.8%-100.0%-82.5%-67.2%
alltimeall time-82.6%-96.9%-82.8%-100.0%-82.5%-99.2%

Agile Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Jun 2024
-
$102.00 K(-1.0%)
$403.00 K(+1.8%)
Mar 2024
-
$103.00 K(+3.0%)
$396.00 K(+2.6%)
Dec 2023
$386.00 K(-74.8%)
$100.00 K(+2.0%)
$386.00 K(+2.4%)
Sep 2023
-
$98.00 K(+3.2%)
$377.00 K(-30.3%)
Jun 2023
-
$95.00 K(+2.2%)
$541.00 K(-47.9%)
Mar 2023
-
$93.00 K(+2.2%)
$1.04 M(-32.3%)
Dec 2022
$1.53 M(-31.0%)
$91.00 K(-65.3%)
$1.53 M(-24.0%)
Sep 2022
-
$262.00 K(-55.8%)
$2.02 M(-12.6%)
Jun 2022
-
$593.00 K(+0.9%)
$2.31 M(+1.9%)
Mar 2022
-
$588.00 K(+2.3%)
$2.27 M(+1.9%)
Dec 2021
$2.22 M(+705.4%)
$575.00 K(+4.2%)
$2.22 M(+21.2%)
Sep 2021
-
$552.00 K(+0.4%)
$1.83 M(+43.1%)
Jun 2021
-
$550.00 K(+0.7%)
$1.28 M(+64.8%)
Mar 2021
-
$546.00 K(+193.5%)
$778.00 K(+181.9%)
Dec 2020
$276.00 K(+69.3%)
$186.00 K(>+9900.0%)
$276.00 K(+109.1%)
Sep 2020
-
$0.00(-100.0%)
$132.00 K(-23.3%)
Jun 2020
-
$46.00 K(+4.5%)
$172.00 K(+4.9%)
Mar 2020
-
$44.00 K(+4.8%)
$164.00 K(+0.6%)
Dec 2019
$163.00 K(+608.7%)
$42.00 K(+5.0%)
$163.00 K(+29.4%)
Sep 2019
-
$40.00 K(+5.3%)
$126.00 K(+37.0%)
Jun 2019
-
$38.00 K(-11.6%)
$92.00 K(+53.3%)
Mar 2019
-
$43.00 K(+760.0%)
$60.00 K(+160.9%)
Dec 2018
$23.00 K
$5000.00(-16.7%)
$23.00 K(-8.0%)
DateAnnualQuarterlyTTM
Sep 2018
-
$6000.00(0.0%)
$25.00 K(+4.2%)
Jun 2018
-
$6000.00(0.0%)
$24.00 K(0.0%)
Mar 2018
-
$6000.00(-14.3%)
$24.00 K(+4.3%)
Dec 2017
$23.00 K(+21.1%)
$7000.00(+40.0%)
$23.00 K(+9.5%)
Sep 2017
-
$5000.00(-16.7%)
$21.00 K(0.0%)
Jun 2017
-
$6000.00(+20.0%)
$21.00 K(+5.0%)
Mar 2017
-
$5000.00(0.0%)
$20.00 K(+5.3%)
Dec 2016
$19.00 K(+5.6%)
$5000.00(0.0%)
$19.00 K(+5.6%)
Sep 2016
-
$5000.00(0.0%)
$18.00 K(+5.9%)
Jun 2016
-
$5000.00(+25.0%)
$17.00 K(0.0%)
Mar 2016
-
$4000.00(0.0%)
$17.00 K(-5.6%)
Dec 2015
$18.00 K(+50.0%)
$4000.00(0.0%)
$18.00 K(-1.6%)
Sep 2015
-
$4000.00(-20.0%)
$18.30 K(+7.6%)
Jun 2015
-
$5000.00(0.0%)
$17.00 K(+17.2%)
Mar 2015
-
$5000.00(+16.3%)
$14.50 K(+19.8%)
Dec 2014
$12.00 K(0.0%)
$4300.00(+59.3%)
$12.10 K(+13.1%)
Sep 2014
-
$2700.00(+8.0%)
$10.70 K(-2.7%)
Jun 2014
-
$2500.00(-3.8%)
$11.00 K(-5.2%)
Mar 2014
-
$2600.00(-10.3%)
$11.60 K(-4.1%)
Dec 2013
$12.00 K(-49.4%)
$2900.00(-3.3%)
$12.10 K(+31.5%)
Sep 2013
-
$3000.00(-3.2%)
$9200.00(+48.4%)
Jun 2013
-
$3100.00(0.0%)
$6200.00(+100.0%)
Mar 2013
-
$3100.00
$3100.00
Dec 2012
$23.70 K
-
-

FAQ

  • What is Agile Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Agile Therapeutics?
  • What is Agile Therapeutics annual D&A year-on-year change?
  • What is Agile Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Agile Therapeutics?
  • What is Agile Therapeutics quarterly D&A year-on-year change?
  • What is Agile Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Agile Therapeutics?
  • What is Agile Therapeutics TTM D&A year-on-year change?

What is Agile Therapeutics annual depreciation & amortization?

The current annual D&A of AGRX is $386.00 K

What is the all time high annual D&A for Agile Therapeutics?

Agile Therapeutics all-time high annual depreciation & amortization is $2.22 M

What is Agile Therapeutics annual D&A year-on-year change?

Over the past year, AGRX annual depreciation & amortization has changed by -$1.15 M (-74.84%)

What is Agile Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of AGRX is $102.00 K

What is the all time high quarterly D&A for Agile Therapeutics?

Agile Therapeutics all-time high quarterly depreciation & amortization is $593.00 K

What is Agile Therapeutics quarterly D&A year-on-year change?

Over the past year, AGRX quarterly depreciation & amortization has changed by $0.00 (0.00%)

What is Agile Therapeutics TTM depreciation & amortization?

The current TTM D&A of AGRX is $403.00 K

What is the all time high TTM D&A for Agile Therapeutics?

Agile Therapeutics all-time high TTM depreciation & amortization is $2.31 M

What is Agile Therapeutics TTM D&A year-on-year change?

Over the past year, AGRX TTM depreciation & amortization has changed by $0.00 (0.00%)